Tag
Gufic Biosciences Limited
5 articles
Gufic Biosciences is demonstrating robust financial performance and strategic expansion, highlighted by a 58% year-over-year increase in profit after tax for the second quarter of fiscal year 2027. The company's revenue grew by 25% year-over-year, driven by international business growth with new registrations and orders in key markets like Saudi Arabia and Azerbaijan. Furthermore, Gufic is advancing its regulated market entry plans with successful US FDA pre-approval inspections at its Indore facility and anticipates EU GMP certification, alongside strengthening its board with the appointment of Dr. Reeta Shah as an independent director. An ESG rating of 69.7/100 further underscores the company's commitment to sustainability, positioning Gufic for continued growth and investor interest.
Gufic Biosciences Q2 Earnings Call Audio Upload
Gufic Biosciences uploaded audio recording of Q2 FY27 earnings conference call held on November 16, 2026.
The conference call was conducted at 4:30 PM IST as part of quarterly results disclosure requi
Gufic Biosciences Q2 FY27 PAT Rises 58% YoY
Gufic Biosciences reported Q2 FY27 revenue of ₹288.4 crore and PAT of ₹23.5 crore, representing 25% YoY revenue growth and 58% YoY PAT growth.
The company made significant progress with its Indore fac
Gufic Biosciences Appoints Dr. Reeta Shah as Independent Director
Gufic Biosciences appointed Dr. Reeta Shah as an Additional Non-Executive Independent Director effective December 1, 2026.
The appointment is for a first term of five years and is subject to sharehold
Gufic Biosciences Q2 Net Profit Rises 57% YoY
Gufic Biosciences reported Q2 FY27 standalone net profit of ₹234.89 lakh, a 57% increase from ₹149.37 lakh in Q2 FY26.
Consolidated revenue for Q2 FY27 reached ₹2,892.77 lakh, up 22% YoY from ₹2,370.7
Gufic Biosciences Assigned 69.7/100 ESG Rating
Gufic Biosciences discloses receipt of an independent ESG rating of 69.7/100 (Medium category) from SES ESG Research for FY 2025-26.
The rating was assigned based on publicly available information wit